Company intelligence / Profile preview

innomedis

North Rhine-Westphalia, Germanyinnomedis.com ↗

Ownership: Private
Development stage: Other

Overview

All core products are commercially available and CE-certified for use in Europe. The company emphasizes high quality standards and regular audits throughout production processes. There is no mention of ongoing clinical trials or investigational-stage therapeutics—products appear to be marketed directly under existing regulatory frameworks for medical devices rather than pharmaceuticals requiring staged clinical trials.

Therapeutic areas: Ophthalmology
Modalities: DeviceFood supplement
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on innomedis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on innomedis.

Explore the full profile